Chief Executive Officer & Chief Scientific Officer

Dr Tim Morley

Dr Morley is responsible for leading Aquapharm's in-house R&D programmes which address both pharmaceutical drug discovery and functional ingredient opportunities for the personal care and nutrition industries. Dr Morley gained his PhD in Mechanistic Toxicology at Aberdeen University and holds an MSc in Biopharmacy, BSc in Applied Biochemistry and BSc in Pharmacology, and is a Board Certified Toxicologist. He has over 20 years' experience in the pharmaceutical industry in drug discovery and development, both with Big Pharma and start-up companies, and was involved in the development of marketed products Lamotrigine and Mivacurium. Prior to joining Aquapharm in July 2010, Dr Morley spent thirteen years in a number of directorial positions at Vernalis, as Senior Director of Biological Sciences and Ardana Bioscience as Vice President of Preclinical Sciences. Dr Morley has directed the development of compounds for the treatment of prostate cancer, growth hormone deficiency, obesity, and Parkinson's disease, from discovery to clinical trials, and is named inventor on several patents.

Chief Technology Officer & Founder

Dr Andrew Mearns Spragg FRSA FSB

Andrew gained a first class honours degree and PhD in marine microbiology from Heriot-Watt University and grew the business from a university "spin-out" to a company of 27 FTEs. Since founding the business, Andrew has successfully raised over £10m in equity and grant finance. He developed the company whilst holding a Royal Society of Edinburgh Enterprise Fellowship in biotechnology; was awarded a John Logie Baird Award in Medical and Academic Science; and was also the recipient of the 2007 Gannochy Innovation Medal, and prize, from the Royal Society of Edinburgh in recognition of his achievements in biotechnology and innovation. In 2008, Andrew's entrepreneurial achievements were further recognised when he won the Ernst & Young Entrepreneur of the year 2008 in Health Care (Scotland) prize.

Chief Business Officer

Bertrand Lehuu, Pharm D

Bertrand Lehuu has 28 years' experience in senior roles in pharmaceutical and biotechnology companies in Switzerland, UK, France and Italy. He recently joined Aquapharm as Senior Vice President (SVP) - Pharma Business. Bertrand is an internationally known bio-pharmaceutical deal-maker and now responsible for business development for Aquapharm. After gaining his Doctorate of Pharmacy from Paris University, Bertrand built his career as a Business Development specialist in the Pasteur Institute, Flamel Technologies, F.Hoffmann-La Roche Ltd., Basilea, Neuro3d, BioXell and most recently PharmaSwiss. Bertrand will play a strategic role in the development and future growth of the company.